North American tick-borne diseases.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001096:Arachnid Vectors; D003121:Colorado Tick Fever / Q000503:physiopathology; D006801:Humans; D008193:Lyme Disease / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology; D009656:North America; D011379:Prognosis; D011778:Q Fever / Q000188:drug therapy / Q000503:physiopathology; D012373:Rocky Mountain Spotted Fever / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology; D013985:Tick Paralysis / Q000503:physiopathology; D013987:Ticks; D014406:Tularemia / Q000188:drug therapy / Q000503:physiopathology / Q000635:transmission
D000900:Anti-Bacterial Agents